| UHC Surest Medical and Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Surest Medical and Drug | Treatment of Temporomandibular Joint Disorders - Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| Cigna | Authorized Generics - (A008) | 2026-03-01 |
| BCBS California | Diagnosis of Obstructive Sleep Apnea Syndrome | 2026-03-01 |
| BCBS California | Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | 2026-03-01 |
| BCBS California | Electrostimulation and Electromagnetic Therapy for Treating Wounds | 2026-03-01 |
| BCBS California | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms | 2026-03-01 |
| BCBS California | Endovascular Stent Grafts for Disorders of the Thoracic Aorta | 2026-03-01 |
| BCBS California | Applied Behavioral Analysis for Autism Spectrum Disorder or Pervasive Developmental Disorder | 2026-03-01 |
| BCBS California | Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer | 2026-03-01 |